Efficacy of Tofacitinib as an Induction Agent in Severe Alopecia Areata Compared to Oral Betamethasone Weekly Pulse

    Rhea Ahuja, Vishal Patel, Ayush Jain, Neha Taneja, Somesh Gupta
    Image of study
    TLDR Tofacitinib is effective for severe alopecia areata, similar to oral betamethasone.
    The study evaluates the efficacy of tofacitinib as an induction agent for severe alopecia areata (AA), characterized by ≥ 50% scalp hair loss, in comparison to the standard oral mini-pulse (OMP) therapy. The findings suggest that tofacitinib is a promising induction agent for patients with severe AA, showing comparable results to OMP. However, for patients who do not respond adequately to tofacitinib, a trial of pulse steroids may be considered as an alternative treatment option.
    Discuss this study in the Community →

    Related Community Posts Join

    6 / 6 results

    Related Research

    3 / 3 results